Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02160925 · ClinicalTrials.gov registry record · NA
Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT02160925: Completed NA study, sponsored by Johns Hopkins University.
NCT02160925 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02160925, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
The objective of this study is to investigate the utility of 99mTc-sestamibi SPECT/CT imaging for the diagnosis of renal oncocytomas.
Interventions
- OTHER Preoperative 99mTc-Sestamibi SPECT/CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2014-05 |
| Est. Completion | 2018-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02160925
The ClinicalTrials.gov registry entry for NCT02160925 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Preoperative 99mTc-Sestamibi SPECT/CT is the first listed.
NCT02160925 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02160925 about?
NCT02160925 is a clinical study titled "Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma". The objective of this study is to investigate the utility of 99mTc-sestamibi SPECT/CT imaging for the diagnosis of renal oncocytomas.
What is the current status of trial NCT02160925?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2014-05. Estimated completion is 2018-06.
What interventions are being tested in trial NCT02160925?
The interventions under investigation include: Preoperative 99mTc-Sestamibi SPECT/CT (OTHER).
Who is sponsoring clinical trial NCT02160925?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.